Mundipharma
David James FCA is a seasoned finance professional with extensive experience in financial reporting, consolidation, and transfer pricing. Currently serving as the Transfer Pricing Lead at Mundipharma since May 2023, David previously held the position of Chief Financial Officer at Pembridge Resources Plc, overseeing finance, company secretarial duties, and cash flow management while preparing consolidated accounts and revenue recognition documentation for a copper mine. David's expertise includes interim and consultancy roles with companies such as Vesuvius, Signature Aviation plc, BBOXX, and QUARTO PUBLISHING PLC, focusing on improving financial reporting processes and supporting group reporting needs. David has also managed international tax reporting and provided accounting consultancy services for organizations like Brand Energy & Infrastructure Services and IRIS Software. David holds a BSocSc in International Studies from the University of Birmingham.
This person is not in any offices
Mundipharma
5 followers
The Mundipharma global network of independent associated companies shares a common purpose to identify and accelerate the development of meaningful medicines that add value for patients and healthcare providers around the globe. Founded in the US by two physicians in 1952 and still privately owned, the network has a presence in over 120 countries. In Europe, the network employees more than 2,000 employees from R&D to manufacturing & supply and commercial, and with revenues in excess of €1 billion. At Mundipharma we strive for one high performing and learning environment where individuals can make a real difference. We have a strong track record of building successful alliances to license, develop and market medicines that improve patients’ lives, while also providing attractive options to financially constrained healthcare systems. Consistent with our entrepreneurial heritage, we like to think that we see what others don’t by challenging conventional wisdom and asking different and challenging questions. By working in partnership with all our stakeholders, the Mundipharma network develops medicines that create value for patients, payers and wider healthcare systems. We have built a European portfolio of medicines to create value for patients, payers and wider healthcare systems across important therapeutic areas such as diabetes, respiratory, oncology, pain and biosimilars.